JUN 27, 2024 10:00 AM PDT

Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors

Sponsored by: QIAGEN
Speakers

Event Date & Time
Date: June 27, 2024
Time: 10:00am PDT, 12:00pm CDT, 1:00pm PDT
Abstract
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes, targeted NGS is not only a cost-effective solution, but can rapidly deliver insights into a tumor molecular profile.
 
To address this challenge, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels, named “Glioma” and “Routine Diagnostics”, targeting single nucleotide variations, insertions/deletions, fusions, and copy number variations of tumor-associated essential genes.
 
In this webinar, attendees will:
  • Understand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis
  • Learn about the design and application of these NGS panels
  • Gain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

You May Also Like
Loading Comments...